Literature DB >> 20592096

Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.

Yang Yang1, Ming Xia, Ming Tan, Pengwei Huang, Weiming Zhong, Xiao Li Pang, Bonita E Lee, Jarek Meller, Tao Wang, Xi Jiang.   

Abstract

The predominance and continual emergence of new variants in GII-4 noroviruses (NVs) in recent years have raised questions about the role of host immunity and histo-blood group antigens (HBGAs) in NV evolution. To address these questions, we performed a genetic and phenotypic characterization of GII-4 variants circulating in the past decade (1998 to 2008). Ninety-three GII-4 sequences were analyzed, and of them, 16 strains representing 6 genetic clusters were selected for further characterization. The HBGA binding properties were determined by both saliva- and oligosaccharide-binding assays using P particles as a model of NV capsid. The antigenic properties were also examined by enzyme immunoassay (EIA), Western blot analysis, and receptor blocking assay, using P-particle-specific antibodies from immunized mice and GII-4 virus-infected patients. Our results showed that 15 of the 16 GII-4 viruses bound to saliva of all A, B, and O secretors. Oligosaccharide binding assays yielded largely consistent results, although the binding affinities to some oligosaccharides varied among some strains. The only nonbinder had a mutation in the binding site. While antigenic variations were detected among the 16 strains, significant cross-blocking on the HBGA binding was also noted. Sequence alignment revealed high conservation of HBGA binding interfaces with some variations in adjacent regions. Taken together, our data suggested that the ability of GII-4 to recognize different secretor HBGAs persisted over the past decade, which may explain the predominance of GII-4 over other genotypes. Our data also indicated that both the host immunity and HBGAs play a role in NV evolution. While host immunity may continue driving NV for antigenic change, the functional selection by the HBGAs tends to lock the architecture of the capsid/HBGA interfaces and allows only limited variations outside the HBGA binding sites. A potential outcome of such counterselection between theses two factors in NV evolution is discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592096      PMCID: PMC2937647          DOI: 10.1128/JVI.02614-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  Association of histo-blood group antigens with susceptibility to norovirus infection may be strain-specific rather than genogroup dependent.

Authors:  Ming Tan; Xi Jiang
Journal:  J Infect Dis       Date:  2008-09-15       Impact factor: 5.226

2.  Emergence of the GII4/2006b variant and recombinant noroviruses in China.

Authors:  Miao Jin; Hua-ping Xie; Zhao-jun Duan; Na Liu; Qing Zhang; Bing-shan Wu; Hui-ying Li; Wei-xia Cheng; Su-hua Yang; Jie-mei Yu; Zi-qian Xu; Shu-xian Cui; Lin Zhu; Ming Tan; Xi Jiang; Zhao-yin Fang
Journal:  J Med Virol       Date:  2008-11       Impact factor: 2.327

3.  An improved general amino acid replacement matrix.

Authors:  Si Quang Le; Olivier Gascuel
Journal:  Mol Biol Evol       Date:  2008-03-26       Impact factor: 16.240

4.  Association of histo-blood group antigens and susceptibility to norovirus infections.

Authors:  Barry H G Rockx; Harry Vennema; Christian J P A Hoebe; Erwin Duizer; Marion P G Koopmans
Journal:  J Infect Dis       Date:  2005-01-25       Impact factor: 5.226

5.  Structural basis for the receptor binding specificity of Norwalk virus.

Authors:  Weiming Bu; Aygun Mamedova; Ming Tan; Ming Xia; Xi Jiang; Rashmi S Hegde
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

6.  Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study.

Authors:  Ming Tan; Ming Xia; Sheng Cao; Pengwei Huang; Tibor Farkas; Jarek Meller; Rashmi S Hegde; Xuemei Li; Zihe Rao; Xi Jiang
Journal:  Virology       Date:  2008-08-08       Impact factor: 3.616

7.  Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding.

Authors:  Haruko Shirato; Satoko Ogawa; Hiromi Ito; Takashi Sato; Akihiko Kameyama; Hisashi Narimatsu; Zheng Xiaofan; Tatsuo Miyamura; Takaji Wakita; Koji Ishii; Naokazu Takeda
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

8.  Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus.

Authors:  Jae-Mun Choi; Anne M Hutson; Mary K Estes; B V Venkataram Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-02       Impact factor: 11.205

Review 9.  Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations.

Authors:  Eric F Donaldson; Lisa C Lindesmith; Anna D Lobue; Ralph S Baric
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

10.  Phylogeny.fr: robust phylogenetic analysis for the non-specialist.

Authors:  A Dereeper; V Guignon; G Blanc; S Audic; S Buffet; F Chevenet; J-F Dufayard; S Guindon; V Lefort; M Lescot; J-M Claverie; O Gascuel
Journal:  Nucleic Acids Res       Date:  2008-04-19       Impact factor: 16.971

View more
  36 in total

1.  A candidate dual vaccine against influenza and noroviruses.

Authors:  Ming Xia; Ming Tan; Chao Wei; Weiming Zhong; Leyi Wang; Monica McNeal; Xi Jiang
Journal:  Vaccine       Date:  2011-08-11       Impact factor: 3.641

2.  Molecular epidemiology of oyster-related human noroviruses and their global genetic diversity and temporal-geographical distribution from 1983 to 2014.

Authors:  Yongxin Yu; Hui Cai; Linghao Hu; Rongwei Lei; Yingjie Pan; Shuling Yan; Yongjie Wang
Journal:  Appl Environ Microbiol       Date:  2015-08-28       Impact factor: 4.792

3.  Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

Authors:  Kari Debbink; Lisa C Lindesmith; Eric F Donaldson; Veronica Costantini; Martina Beltramello; Davide Corti; Jesica Swanstrom; Antonio Lanzavecchia; Jan Vinjé; Ralph S Baric
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

4.  New strains of norovirus and the mystery of viral gastroenteritis epidemics.

Authors:  Bonita E Lee; Xiao-Li Pang
Journal:  CMAJ       Date:  2013-09-03       Impact factor: 8.262

5.  Affinities of recombinant norovirus P dimers for human blood group antigens.

Authors:  Ling Han; Pavel I Kitov; Elena N Kitova; Ming Tan; Leyi Wang; Ming Xia; Xi Jiang; John S Klassen
Journal:  Glycobiology       Date:  2012-10-30       Impact factor: 4.313

6.  Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age.

Authors:  Tammy Bui; Jacob Kocher; Yanru Li; Ke Wen; Guohua Li; Fangning Liu; Xingdong Yang; Tanya LeRoith; Ming Tan; Ming Xia; Weiming Zhong; Xi Jiang; Lijuan Yuan
Journal:  J Gen Virol       Date:  2013-06-26       Impact factor: 3.891

7.  Complete genome sequence of a new-genotype porcine norovirus isolated from piglets with diarrhea.

Authors:  Quan Shen; Wen Zhang; Shixing Yang; Li Cui; Xiuguo Hua
Journal:  J Virol       Date:  2012-06       Impact factor: 5.103

Review 8.  Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.

Authors:  Ming Tan; Xi Jiang
Journal:  Nanomedicine (Lond)       Date:  2012-06       Impact factor: 5.307

9.  Effect of grape seed extract on human norovirus GII.4 and murine norovirus 1 in viral suspensions, on stainless steel discs, and in lettuce wash water.

Authors:  Dan Li; Leen Baert; Dongsheng Zhang; Ming Xia; Weiming Zhong; Els Van Coillie; Xi Jiang; Mieke Uyttendaele
Journal:  Appl Environ Microbiol       Date:  2012-08-17       Impact factor: 4.792

10.  A dual vaccine candidate against norovirus and hepatitis E virus.

Authors:  Leyi Wang; Dianjun Cao; Chao Wei; Xiang-Jin Meng; Xi Jiang; Ming Tan
Journal:  Vaccine       Date:  2013-11-27       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.